Rectal cancer surgery : what's in a name?

IF 1.5 4区医学 Q2 Medicine Acta Gastro-Enterologica Belgica Pub Date : 2019-01-01

N Komen, P Dewint, S Van den Broeck, S Pauli, H de Schepper

引用次数: 0

Abstract

The field of rectal cancer treatment is a dynamic and changing field, due to better understanding of the pathology and new medical treatment options, but perhaps mostly due to innovations in the surgical approach. Surgery is the cornerstone for rectal cancer treatment. Currently, Total Mesorectal Excision is the gold standard. After evolution towards laparoscopic TME, improving technology has led to the development of platforms that allow transanal TME and robotic TME. In addition, local excision can be performed safer and more accurately by means of Transanal Endoscopic Microsurgery (TEM), TransAnal Minimally Invasive Surgery or Endoscopic Submucosal Dissection (ESD), possibly avoiding TME. The aim of this review is to summarize the different surgical techniques and approaches for rectal cancer in function of tumor stage and describe the specifics of the technique.

微信好友朋友圈 QQ好友复制链接

本刊更多论文

直肠癌手术:名字有什么关系?

直肠癌治疗领域是一个动态和不断变化的领域，由于对病理学的更好理解和新的医学治疗选择，但可能主要是由于手术方法的创新。手术是直肠癌治疗的基石。目前，全肠系膜切除术是金标准。在向腹腔镜TME发展之后，技术的改进导致了经肛门TME和机器人TME平台的发展。此外，经肛门内镜显微手术(TEM)、经肛门微创手术(ESD)或内镜粘膜下剥离术(ESD)可以更安全、更准确地进行局部切除，可能避免TME。本综述的目的是总结不同的手术技术和入路的直肠癌在肿瘤分期的功能和描述技术的特点。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Acta Gastro-Enterologica Belgica 医学-胃肠肝病学

CiteScore

2.80

自引率

20.00%

发文量

审稿时长

>12 weeks

期刊介绍： The Journal Acta Gastro-Enterologica Belgica principally publishes peer-reviewed original manuscripts, reviews, letters to editors, book reviews and guidelines in the field of clinical Gastroenterology and Hepatology, including digestive oncology, digestive pathology, as well as nutrition. Pure animal or in vitro work will not be considered for publication in the Journal. Translational research papers (including sections of animal or in vitro work) are considered by the Journal if they have a clear relationship to or relevance for clinical hepato-gastroenterology (screening, disease mechanisms and/or new therapies). Case reports and clinical images will be accepted if they represent an important contribution to the description, the pathogenesis or the treatment of a specific gastroenterology or liver problem. The language of the Journal is English. Papers from any country will be considered for publication. Manuscripts submitted to the Journal should not have been published previously (in English or any other language), nor should they be under consideration for publication elsewhere. Unsolicited papers are peer-reviewed before it is decided whether they should be accepted, rejected, or returned for revision. Manuscripts that do not meet the presentation criteria (as indicated below) will be returned to the authors. Papers that go too far beyond the scope of the journal will be also returned to the authors by the editorial board generally within 2 weeks. The Journal reserves the right to edit the language of papers accepted for publication for clarity and correctness, and to make formal changes to ensure compliance with AGEB’s style. Authors have the opportunity to review such changes in the proofs.